Epilepsy Home > Zonegran Uses

Zonegran uses are primarily concerned with treating epilepsy in people age 16 and over who experience a certain type of seizure called partial seizures or focal seizures. The drug is not approved for use by children younger than this. It is believed to work by blocking sodium channels in the brain. "Off-label" Zonegran uses include the treatment of other types of seizures.

An Introduction to Zonegran Uses

Zonegran® (zonisamide) is a prescription medication used for epilepsy. In particular, Zonegran is approved for treating epilepsy in people who experience a certain type of seizure called a partial seizure or focal seizure. It is approved to be used along with other seizure medications, but not to be used alone.

Zonegran Uses for Epilepsy and Partial Seizures

Epilepsy is a brain condition that occurs when there are sudden, brief changes in the electrical system of the brain. These changes in brain activity can lead to seizures (see Epilepsy Symptoms). Depending on which part of the brain is involved, seizures may affect a person's consciousness, body movements, emotions, or senses.
In over half of all cases, the cause of epilepsy is not known. When the cause is known, it may be one of the following:
There are over 30 different types of seizures a person with epilepsy may experience. These seizures are generally classified into two main categories -- partial seizures (also known as focal seizures) and generalized seizures.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.